Epilat Retard 20 Tablets

Epilat Retard 20 Tablets

Description:

Epilat Retard 20 Tablets are a prescription antihypertensive and antianginal medicine containing nifedipine, a dihydropyridine calcium channel blocker. Each tablet is a sustained-release (sr) film-coated formulation designed to provide gradual and prolonged nifedipine release, helping to control high blood pressure and prevent angina attacks over 24 hours. By relaxing peripheral and coronary blood vessels, Epilat Retard reduces vascular resistance, improves blood flow, and decreases myocardial oxygen demand, supporting long-term cardiovascular health and blood pressure management under medical supervision.

Indications:

• Treatment of essential (primary) hypertension in adults, as part of a comprehensive blood pressure control plan.
• Management of chronic stable angina pectoris (effort angina) to reduce frequency and severity of chest pain episodes.
• Management of vasospastic (Prinzmetal’s) angina by dilating coronary arteries and preventing coronary spasm.
• May be used as part of combination therapy in patients with hypertension or angina not adequately controlled with monotherapy, as directed by a physician.

Active Ingredients / Key Components:

• Nifedipine – 20 mg sustained-release (sr) per film-coated tablet.
• Excipients: film-coating agents, fillers, and stabilizers (full excipient list and exact concentrations , please check the product leaflet or the manufacturer’s official website; refer to the official package leaflet for details).

Dosage & Administration / How to Use:

• Dosage must always be individualized and determined by the treating physician based on the patient’s condition and response.
• Typical adult dose for hypertension or chronic stable angina: commonly 20 mg once or twice daily using sustained-release tablets; your doctor may adjust the dose within the recommended range according to blood pressure and symptom control. Exact dosing regimen should follow the prescribing information and physician’s instructions.
• Swallow the tablets whole with a sufficient amount of water. Do not crush, chew, or break the sustained-release tablets, as this may alter the controlled-release profile and increase side effects.
• Preferably take at the same time(s) each day to maintain consistent blood levels.
• Can be taken with or without food; however, take consistently in the same manner (always with food or always without) as advised by your doctor.
• Do not abruptly stop taking Epilat Retard without medical advice, as sudden discontinuation may worsen angina or blood pressure control.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.

Clinical Benefits:

• Helps lower and control high blood pressure, reducing the risk of cardiovascular complications such as stroke and heart attack when used as part of long-term management.
• Reduces frequency and severity of angina attacks by dilating coronary arteries and improving myocardial oxygen supply-demand balance.
• Decreases peripheral vascular resistance and afterload, improving cardiac output without compromising cerebral or renal perfusion.
• Provides sustained 20 mg nifedipine release through retard (sr) technology, offering more stable blood levels and prolonged therapeutic effect with convenient dosing.
• Relaxes smooth muscle in peripheral and coronary vessels, which may also support improved circulation and reduced vascular spasm.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to nifedipine or any component of the formulation.
• Contraindicated in patients with severe aortic stenosis, cardiogenic shock, or unstable angina unless specifically directed and closely monitored by a cardiologist.
• Use with caution in patients with heart failure, significant hypotension, or severe hepatic impairment; dose adjustment and close monitoring may be required.
• May cause a significant drop in blood pressure, especially at treatment initiation or dose increase; stand up slowly to minimize dizziness or fainting.
• Grapefruit juice may increase nifedipine blood levels and should generally be avoided during treatment unless otherwise advised by your doctor.
• May interact with other antihypertensives, beta-blockers, certain antibiotics, antifungals, and antiepileptics; inform your doctor about all medications and supplements you are taking.
• Consult your doctor before use if pregnant or planning pregnancy. Nifedipine should be used in pregnancy only if clearly needed and under strict medical supervision.
• Consult your doctor before use if breastfeeding; nifedipine may pass into breast milk and a risk–benefit assessment is required.
• Use with caution in patients with liver disease, kidney disease, diabetes, or those prone to hypotension.
• May cause dizziness, fatigue, or visual disturbances; avoid driving or operating machinery until you know how the medicine affects you.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects: headache, flushing, dizziness, lightheadedness, palpitations, ankle or leg swelling (peripheral edema), nausea, and fatigue.
• Less common side effects: gastrointestinal discomfort, constipation, heartburn, rash, or mild gingival overgrowth.
• Serious side effects (seek immediate medical attention): severe dizziness or fainting, marked drop in blood pressure, worsening chest pain or new-onset angina, shortness of breath, signs of allergic reaction (swelling of face, lips, tongue, or throat; severe rash; difficulty breathing).
• If any side effects are severe, persistent, or concerning, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the package insert (exact storage temperature is not available in the provided information; refer to the official leaflet).

Specifications:

• Product type: prescription antihypertensive and antianginal medicine.
• Active ingredient strength: nifedipine 20 mg sustained-release (sr) per film-coated tablet.
• Form: sustained-release film-coated tablet.
• Pack size: 20 tablets per pack.
• Intended use: adult patients as directed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.